Loch T, Cianciara J
Zakładu Immunopatologii, Instytut Chorób Zakaźnych i Pasozytnicyzych AM, Warszawie.
Pol Arch Med Wewn. 1992 Jun;87(6):345-51.
The aim of the study was to test the clinical value of HBV DNA polymerase (DNAp) determination in patients with various forms of HBV infection, namely: acute hepatitis, chronic hepatitis, cirrhosis and healthy HBV carriers. The determination of DNAp was found to be particularly useful in patients with chronic HBV infection with active virus replication (HBeAg+) independent of histopathological changes.
该研究的目的是检测乙肝病毒脱氧核糖核酸聚合酶(DNAp)测定在各种形式乙肝病毒感染患者中的临床价值,这些患者包括:急性肝炎、慢性肝炎、肝硬化患者以及健康乙肝病毒携带者。结果发现,DNAp测定对于慢性乙肝病毒感染且病毒活跃复制(HBeAg阳性)的患者尤为有用,且与组织病理学变化无关。